CCL5 secreted from TNF-α-primed hBMMSCs also showed the ability to promote CRC progression and EMT via the CCL5/CCR1/β-catenin/Slug signaling pathway [137]. This evidence concerns the gene CCL5 and colorectal carcinoma.